SUMMIT THERAPEUTICS INC CLL OPT 10/26 14.0 CAL Stock

SUMMIT THERAPEUTICS INC CLL OPT 10/26 14.0 CAL Stock is a security (CUSIP 8500699RN) tracked across SEC portfolio filings. 1 institutional managers reported $7K on Form 13F as of 2026-06-30.

Summary

• Issuer: SUMMIT THERAPEUTICS INC CLL OPT 10/26 14.0 CAL
• Class: Stock
• CUSIP: 8500699RN
• 13F holders: 1
• 13F value: $7K
• 13F period: 2026-06-30
• N-PORT fund positions: 0

Top institutional holders (Form 13F)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search